ETF PRO AIAugust 23, 2026
PBE Invesco Dynamic Biotechnology & Genome ETF
Fund tearsheet · data as of the latest session · August 23, 2026
ONE YEAR OF DAILY CLOSES
0.58%expense ratio
$398Mfund assets
+18.5%return, YTD
+41.8%return, 1 year
+$90Mnet flow, 1 month
+$88Mnet flow, 1 year
18.9%realized volatility, 1y
-11.8%worst drawdown, 1y
Top ten holdings
| 1 | REGN REGENERON PHARMACEUTICALS | 5.50% |
| 2 | AMGN AMGEN | 5.44% |
| 3 | VRTX VERTEX PHARMACEUTICALS | 5.24% |
| 4 | CDNA CAREDX | 5.02% |
| 5 | RPRX ROYALTY PHARMA | 4.76% |
| 6 | BIIB BIOGEN | 4.68% |
| 7 | GILD GILEAD SCIENCES | 4.53% |
| 8 | OMER OMEROS | 3.68% |
| 9 | UTHR UNITED THERAPEUTICS | 3.79% |
| 10 | HALO HALOZYME THERAPEUTICS | 3.55% |
PREPARED WITH ETF PRO AI · PRIMARY MARKET DATA · INFORMATIONAL ONLY — NOT AN OFFER, RECOMMENDATION, OR INVESTMENT ADVICE · PAST PERFORMANCE DOES NOT GUARANTEE FUTURE RESULTS